摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(pyrimidin-5-yl)-1H-1,2,4-triazol-5-amine | 1338358-69-2

中文名称
——
中文别名
——
英文名称
3-(pyrimidin-5-yl)-1H-1,2,4-triazol-5-amine
英文别名
5-Amino-3-(5-pyrimidinyl)-1H-1,2,4-triazole;5-pyrimidin-5-yl-1H-1,2,4-triazol-3-amine
3-(pyrimidin-5-yl)-1H-1,2,4-triazol-5-amine化学式
CAS
1338358-69-2
化学式
C6H6N6
mdl
——
分子量
162.154
InChiKey
SEIDUTOXLROQJK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.4
  • 重原子数:
    12
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    93.4
  • 氢给体数:
    2
  • 氢受体数:
    5

文献信息

  • [EN] TRIAZOLES FOR THE TREATMENT OF DEMYELINATING DISEASES<br/>[FR] TRIAZOLES POUR LE TRAITEMENT DE MALADIES LIÉES À LA DÉMYÉLINISATION
    申请人:VERTEX PHARMA
    公开号:WO2016197009A1
    公开(公告)日:2016-12-08
    The invention relates to triazole compounds of formula I and I' or pharmaceutically acceptable salts thereof, useful as modulators of demyelinating diseases: The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention, methods of using the compositions and kits thereof in the treatment of various demyelinating and neurodegenerative diseases, including multiple sclerosis.
    该发明涉及式I和I'的三唑化合物或其药学上可接受的盐,用作脱髓鞘疾病的调节剂:该发明还提供了包括该发明化合物的药学上可接受的组合物,以及在治疗各种脱髓鞘和神经退行性疾病,包括多发性硬化症中使用这些组合物的方法和工具包。
  • [EN] MULTISUBSTITUTED AROMATIC COMPOUNDS AS SERINE PROTEASE INHIBITORS<br/>[FR] COMPOSÉS AROMATIQUES MULTISUBSTITUÉS EN TANT QU'INHIBITEURS DE SÉRINE PROTÉASE
    申请人:VERSEON INC
    公开号:WO2014145986A1
    公开(公告)日:2014-09-18
    There are provided inter alia multisubstituted aromatic compounds useful for the inhibition of kallikrein, which compounds include substituted pyrazolyl or substituted triazolyl. There are additionally provided pharmaceutical compositions. There are additionally provided methods of treating and preventing certain diseases or disorders, which disease or disorder is amenable to treatment or prevention by the inhibition of kallikrein.
    提供了用于抑制激肽酶的多取代芳香化合物,其中这些化合物包括取代吡唑基或取代三唑基。此外还提供了药物组合物。此外还提供了治疗和预防某些疾病或疾病的方法,这些疾病或疾病可通过抑制激肽酶来治疗或预防。
  • MULTISUBSTITUTED AROMATIC COMPOUNDS AS INHIBITORS OF THROMBIN
    申请人:VERSEON CORPORATION
    公开号:US20170326125A1
    公开(公告)日:2017-11-16
    There are provided inter alia multisubstituted aromatic compounds useful for the inhibition of thrombin, which compounds include substituted pyrazolyl or substituted triazolyl. There are additionally provided pharmaceutical compositions. There are additionally provided methods of treating and preventing a disease or disorder, which disease or disorder is amenable to treatment or prevention by the inhibition of thrombin.
    提供了用于抑制凝血酶的多取代芳香化合物,其中化合物包括取代的吡唑基或取代的三唑基。此外还提供了药物组合物。此外还提供了治疗和预防疾病或紊乱的方法,该疾病或紊乱可通过抑制凝血酶进行治疗或预防。
  • MULTISUBSTITUTED AROMATIC COMPOUNDS AS SERINE PROTEASE INHIBITORS
    申请人:VERSEON CORPORATION
    公开号:US20160024047A1
    公开(公告)日:2016-01-28
    There are provided inter alia multisubstituted aromatic compounds useful for the inhibition of kallikrein, which compounds include substituted pyrazolyl or substituted triazolyl. There are additionally provided pharmaceutical compositions. There are additionally provided methods of treating and preventing certain diseases or disorders, which disease or disorder is amenable to treatment or prevention by the inhibition of kallikrein.
    本发明提供了多取代芳香化合物,其中包括取代的吡唑基或取代的三唑基,用于抑制卡利肽酶,另外还提供了制药组合物。本发明还提供了治疗和预防某些疾病或疾病的方法,该疾病或疾病可通过抑制卡利肽酶来治疗或预防。
  • Multisubstituted aromatic compounds as serine protease inhibitors
    申请人:VERSEON CORPORATION
    公开号:US10251872B2
    公开(公告)日:2019-04-09
    There are provided inter alia multisubstituted aromatic compounds useful for the inhibition of kallikrein, which compounds include substituted pyrazolyl or substituted triazolyl. There are additionally provided pharmaceutical compositions. There are additionally provided methods of treating and preventing certain diseases or disorders, which disease or disorder is amenable to treatment or prevention by the inhibition of kallikrein.
    除其他外,还提供了可用于抑制卡利克林的多取代芳香族化合物,这些化合物包括取代的吡唑基或取代的三唑基。 另外还提供了药物组合物。 此外,还提供了治疗和预防某些疾病或失调的方法,这些疾病或失调可通过抑制卡利克林来治疗或预防。
查看更多